Dynavax (DVAX) Reports Q1 Loss of $0.70
Tweet
Share
E-mailGet Alerts DVAX Hot Sheet
Price: $15.50 --0%
Financial Fact:
Research and development: 23.23M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Research and development: 23.23M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.70), versus ($0.97) reported last year. Revenue for the quarter came in at $942 million, versus $627 million reported last year.
For earnings history and earnings-related data on Dynavax (DVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Bristow Group to acquire Berry Aviation for $105 million
- UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
